UK Markets closed
  • NIKKEI 225

    27,824.83
    -259.64 (-0.92%)
     
  • HANG SENG

    28,194.09
    +166.52 (+0.59%)
     
  • CRUDE OIL

    66.36
    +0.99 (+1.51%)
     
  • GOLD FUTURES

    1,866.60
    +28.50 (+1.55%)
     
  • DOW

    34,327.79
    -54.34 (-0.16%)
     
  • BTC-GBP

    31,547.16
    -368.67 (-1.16%)
     
  • CMC Crypto 200

    1,240.95
    +43.03 (+3.59%)
     
  • Nasdaq

    13,379.05
    -50.93 (-0.38%)
     
  • ^FTAS

    4,002.90
    -9.17 (-0.23%)
     

Vistin Pharma ASA: Invitation to Q1 2021 conference call

Vistin Pharma ASA
·1-min read

Oslo, Norway, 16 April 2021

Vistin Pharma ASA will release its first quarter 2021 results on Friday 23rd of April 2021. Vistin Pharma will host a conference call for all shareholders and interested parties on Friday 23rd of April at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in Norwegian.

The first quarter conference call will be available via web and audio through the following access points:

Telephone conference:
Confirmation Code:........ 4598958
International Dial-In:........ +44 (0) 2071 928338
Norway, Oslo:................ +47 21563015
United States, New York: +1 6467413167

Webcast:
https://edge.media-server.com/mmc/p/rso5ngk4

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.